Pharmaceuticals
NPPA slashes cancer drug prices by up to 86%
07 Mar 2017
Since March 2016, there has been "significant price reduction" by up to 86 per cent in some major cancer drugs, and by up to 42 per cent in major diabetic drugs, the drug prices regulator said
Perrigo to sell royalties of multiple sclerosis drug Tysabri to Royalty Pharma for up to $2.85 bn
01 Mar 2017
WHO publishes first list of drug-resistant killer bugs
28 Feb 2017
The list was drawn up to guide and promote research and development of new antibiotics, as part of WHO’s efforts to address growing resistance among bacteria to medicines currently in use
.webp)
